Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Azmi Al Najjar"'
Autor:
Bruno Hurault de Ligny, Jacques Benichou, Pierre-François Westeel, Pierre Marquet, Olivier Toupance, Michel Godin, Yannick Le Meur, Antoine Thierry, Marie-France Hellot, Azmi Al Najjar, Isabelle Etienne, Arnaud François
Publikováno v:
Nephrology Dialysis Transplantation. 25:3096-3106
Background. Although cyclosporine maintenance therapy reduces the risk of acute rejection and increases short-term graft survival in renal transplant recipients, its associated nephrotoxicity increases the risk of chronic graft dysfunction. The dose
Autor:
Tarik Houssaini, Sqalli, Matthias, Buchler, Azmi, Al Najjar, Anne, Paris, Jean-Michel, Halimi, Hubert, Nivet, Philippe, Anthonioz, Philippe, Bourlier, Thanh Hai, Duong, Yvon, Lebranchu
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 20, Iss 6, Pp 1057-1060 (2009)
Autor:
Yvon Lebranchu, Marie-Denise Boulanger, Jean-Frédéric Marlière, Florence Velge-Roussel, Tarik Sqalli Houssaini, Thomas W Hoffmann, Mathias Büchler, Christophe Baron, Jean-Michel Halimi, Alain Goudeau, Azmi Al Najjar
Publikováno v:
Transplantation. 85:1406-1411
Background Cytomegalovirus (CMV) infection is associated with a significant rate of morbidity after organ transplantation. The genetic factors influencing its occurrence have been little investigated. IL-12 plays a crucial role in anti-infectious imm
Autor:
Christian Hiesse, Lionel Rostaing, Thierry Romanet, Edith Renoult, Raj Purgus, T. Besse, Georges Mourad, Patrick Le Pogamp, Jean-Louis Touraine, Jean-Paul Squifflet, Corinne Antoine, Philippe Lang, François Berthoux, Yvon Lebranchu, Denis Glotz, Michèle Kessler, Joseph Rivalan, B Viron, Eric Alamartine, Dominique Durand, Luc Potaux, Pierre Merville, Christophe Baron, Bernard Charpentier, Claire Pouteil-Noble, Michel Olmer, Nicole Lefrançois, P. Vialtel, Azmi Al Najjar, R. Cahen, Valérie Garrigue, J Bedrossian, Christophe Legendre, Françoise Mignon
Publikováno v:
Transplantation. 72:1050-1055
Background. The aim of this study was to compare the efficacy and safety of induction treatment with antithymocyte globulins (ATG) followed by tacrolimus therapy with immediate tacrolimus therapy in renal transplant recipients. Methods. This 12-month
Autor:
Prisca, Mutinelli-Szymanski, Agnès, Caille, François, Tranquart, Azmi, Al-Najjar, Matthias, Büchler, Christelle, Barbet, Jean-Frédéric, Marlière, Philippe, Gatault, Julie, Réault, Christopher, Boin, Valérie, Chatelet, Inass, Laouad, Hubert, Nivet, Yvon, Lebranchu, Jean-Michel, Halimi
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 25(4)
Pulse pressure and urinary albumin excretion were recently identified as risk factors of new-onset diabetes after renal transplantation (NODAT), suggesting that microvascular injury may be implicated in NODAT. However, the relationship between of mic
Autor:
Julie Badin, Matthias Büchler, Yvon Lebranchu, Jean-Michel Halimi, Mélanie Roland, Christelle Barbet, Anne Bretagnol, Hubert Nivet, Azmi Al Najjar, Jean Frédéric Marlière, Laurent Machet
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 23(9)
Nonmelanoma skin cancers (NMSC) are the most common malignant tumors following solid organ transplantation. Risk factors for NMSC mainly include immunosuppression, age, sun exposure and patient phototype. Recent findings have suggested that autosomal
Autor:
Fabienne Di Giambattista, Nassim Kamar, Nicole Lefrançois, Azmi Al Najjar, Jacques Dantal, Christophe Mariat, Pierre-Yves Benhamou, Florence Villemain, Elisabeth Cassuto, Guy Touchard, Olivier Cointault, Michel Delahousse
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 22(7)
Background. New-onset diabetes mellitus (NODM)—a common complication of kidney transplantation—is associated with increases in graft loss, morbidity and mortality. Methods. This is a purely observational study of 527 patients taking a calcineurin
Autor:
Yvon Lebranchu, Magalie Giral, Bruno Giraudeau, Christian Jacquelinet, Jean-Michel Halimi, Christian Hiesse, Hubert Nivet, Azmi Al Najjar, Matthias Büchler
Publikováno v:
Clinical transplantation. 18(6)
The number of older patients living with a functioning kidney graft is increasing. However the safety of the immunosuppressive treatment and quality of life in this population have not yet been determined. All patients grafted in France since 1969, b
Autor:
Hervé Watier, Sandrine Cappellesso, Marie-Denise Boulanger, Bruno Giraudeau, Jean-François Valentin, Azmi Al Najjar, Yvon Lebranchu, Hubert Nivet, Jean-Michel Halimi, Pierre Bardos, Mathias Büchler
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 19(2)
Background. Genetic factors other than HLA have been reported to be associated with the outcome of organ transplantations. Because binding of FasL to its receptor Fas could play an important role in tubulitis and in the death of graft tubular epithel
Autor:
Dominique Richard‐Lenoble, Frédéric Bastides, Hubert Nivet, Matthias Büchler, Séverine Beaudreuil, Maud François, Yvon Lebranchu, Azmi Al Najjar, Tanh Hai Duong
Publikováno v:
Nephrology Dialysis Transplantation. 18:850-851